| A comprehensive pan-cancer molecular study of gynecologic and breast cancers AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ... Cancer cell 33 (4), 690-705. e9, 2018 | 548 | 2018 |
| Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas LA Donehower, T Soussi, A Korkut, Y Liu, A Schultz, M Cardenas, X Li, ... Cell reports 28 (5), 1370-1384. e5, 2019 | 513 | 2019 |
| A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 143 | 2018 |
| Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression G Han, Q Deng, ML Marques-Piubelli, E Dai, M Dang, MCJ Ma, X Li, ... Blood cancer discovery 3 (5), 428-443, 2022 | 41 | 2022 |
| Predictive sampling of rare conformational events in aqueous solution: Designing a generalized orthogonal space tempering method C Lu, X Li, D Wu, L Zheng, W Yang Journal of chemical theory and computation 12 (1), 41-52, 2016 | 18 | 2016 |
| Precision combination therapies based on recurrent oncogenic co-alterations X Li, EK Dowling, G Yan, Z Dereli, B Bozorgui, P Imanirad, JH Elnaggar, ... Cancer Discovery, 2022 | 17 | 2022 |
| Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells P Strati, X Li, Q Deng, ML Marques-Piubelli, J Henderson, G Watson, ... Cell Reports Medicine 4 (8), 2023 | 7 | 2023 |
| A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma P Strati, A Jallouk, Q Deng, X Li, L Feng, R Sun, S Adkins, S Johncy, ... Blood Advances 7 (21), 6785-6789, 2023 | 6 | 2023 |
| A single-cell atlas of CD19 chimeric antigen receptor T cells X Li, J Henderson, MJ Gordon, I Sheikh, LJ Nastoupil, J Westin, C Flowers, ... Cancer cell 41 (11), 1835-1837, 2023 | 4 | 2023 |
| Targeting adaptation to cancer treatment by drug combinations H Wang, A Luna, G Yan, X Li, O Babur, GB Mills, C Sander, A Korkut bioRxiv, 2021.04. 14.439861, 2021 | 3 | 2021 |
| BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer G Yan, A Luna, H Wang, B Bozorgui, X Li, M Sanchez, Z Dereli, ... Cell reports 40 (11), 2022 | 2 | 2022 |
| Recurrent composite markers of cell types and states X Li, A Korkut bioRxiv, 2023.07. 17.549344, 2023 | 1 | 2023 |
| Free energy landscape of a minimalist salt bridge model X Li, C Lv, KM Corbett, L Zheng, D Wu, W Yang Protein Science 25 (1), 270-276, 2016 | 1 | 2016 |
| A prognostic matrix code defines functional glioblastoma phenotypes and niches M Vishnoi, Z Dereli, Z Yin, EK Kong, M Kinali, K Thapa, O Babur, K Yun, ... Research Square, 2023 | | 2023 |
Anil KorkutMD Anderson Cancer CenterVerified email at mdanderson.org
